Aarti Drugs Limited
₹396.00▼ -0.45 (-0.11%)
AARTIDRUGS·NSE·Healthcare
Market Cap
3618.40 Cr
PE Ratio
18.54
Volume
69,619
Day High - Low
399.45 - 392.50
52W High-Low
534.00 - 318.95
₹396.00▼ -0.45 (-0.11%)
Market Cap3618.40 Cr
PE Ratio18.54
Volume69,619
Day High - Low399.45 - 392.50
52W High-Low534.00 - 318.95
Aarti Drugs Limited (AARTIDRUGS): company summary
The company's annual revenue rose 7.5% to ₹2,565 crore, while annual net profit rose 16.0% to ₹195 crore.
Aarti Drugs Limited (AARTIDRUGS) is a micro-cap Healthcare company valued at ₹3,618 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Aarti Drugs Limited last traded at ₹396, modestly down 0.11% on the day.
- Recent developments
- On 2026-08-24, the CFO stated that the company targets 15-16% EBITDA margin through higher Sayakha utilisation and increased Metformin volumes, with plans to expand sales into regulated markets like Western Europe and the US.
- Financial performance
- The company's annual revenue rose 7.5% to ₹2,565 crore, while annual net profit rose 16.0% to ₹195 crore. The latest quarter saw revenue rise 18.9% year-on-year to ₹703 crore, but net profit fell 7.2% to ₹50 crore.
- Valuation multiples
- The stock trades at 18.5 times earnings, a discount to the Healthcare median of 32.0, 2.57 times book value. It yields 0.5%.
- Things to watch
- The stock is 21.2% below its 52-week high. Promoter holding fell 0.60 percentage points in the quarter. Promoter shares pledged amount to 2.50% of promoter holding.
- Where it stands
- The company's latest quarter revenue rose 18.9% year-on-year, but net profit fell 7.2%. Promoter holding decreased by 0.60 percentage points, and the stock is 21.2% below its 52-week high.
Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
4.0/10
Weak
Fair Value
Sign in to see
ROE
12.58%
Average
P/E
18.54x
Fair
Debt / Equity
0.37
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed
Price performance
Day₹392.50
₹399.45
52W₹318.95
₹534.00
DocStoX take
Supported by risk (8.1), but held back by growth (1.1). Risk looks strong at 8.1, but that is offset by growth at 1.1 and momentum at 3.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence4.0
/10
Weak
Quality
Solid
ROE 12.6%
Valuation
Rich
P/E 18.5×
Growth
Flat
Revenue +3.5% 5Y CAGR
Risk
Low risk
D/E 0.37
Momentum
Soft
36% of 52-week range
At a glance
Market Cap
₹3,618 Cr
52W High / Low
₹534 / ₹319
Dividend Yield
0.46%
Promoter Holding
54.07%
EPS (TTM)
₹21.36
Book Value
₹169.70
Key highlights
- Profitable in all of the last 5 years
- Profit shrinking 7% a year
- Growth is weak (1.1/10)
1 Positive3 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Aarti Drugs Limited’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Aarti Drugs Limited peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Aarti Drugs Limited with peers
Aarti Drugs Limited vs Sun Pharmaceutical Industries LimitedAarti Drugs Limited vs Divi's Laboratories LimitedAarti Drugs Limited vs Torrent Pharmaceuticals LimitedAarti Drugs Limited vs Apollo Hospitals Enterprise LimitedAarti Drugs Limited vs Zydus Lifesciences LimitedAarti Drugs Limited vs Laurus Labs Limited
Related tools & concepts
Value Aarti Drugs Limited with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing